Sarepta Therapeutics (SRPT)

Add to Watchlists Create an Alert
20.33 +0.43  +2.16% NASDAQ Jul 29, 4:59PM BATS Real time Currency in USD
View Full Chart
SRPT Price Chart
View All Events

SRPT Events

Date Type Description
06/03/2014 Misc Annual General Meeting for Sarepta Therapeutics Inc
05/22/2014 Misc Sarepta Therapeutics Announces Agreement for Acquisition of Manufacturing Facility in Massachusetts
05/08/2014 08:00 EDT Misc Q1 2014 Sarepta Therapeutics Inc. Earnings Conference Call
05/08/2014 Earnings Q1 2014 Sarepta Therapeutics Inc. Earnings Result. Estimate: -0.78.
02/27/2014 08:00 EDT Misc Sarepta Therapeutics Inc Q4 2013 Earning Conference Call
02/27/2014 Earnings Sarepta Therapeutics Inc Q4 2013 Earning Result. Estimate: -0.70.
11/12/2013 08:00 EDT Misc Sarepta Therapeutics to Announce Third Quarter 2013 Financial Conference Call
11/12/2013 Earnings Sarepta Therapeutics to Announce Third Quarter 2013 Financial Results. Estimate: -0.66.
10/17/2013 12:00 ECT Misc Cambridge, Ma -- (Marketwired) -- 10/10/13 -- Sarepta Therapeutics, Inc. (Nasdaq: Srpt), a Developer of Innovative Rna-based Therapeutics, Will Host a Webcast and Conference Call for the Duchenne Muscular Dystrophy (Dmd) Community on Thursday, Octobe
08/08/2013 08:00 EDT Misc Cambridge, Ma -- (Marketwired) -- 07/25/13 -- Sarepta Therapeutics, Inc. (Nasdaq: Srpt), a Developer of Innovative Rna-based Therapeutics, Will Report Second Quarter Financial Results Before the Nasdaq Global Market Opens on Thursday, August 8, 2013.
View All Performance Charts

SRPT Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Sarepta Therapeutics is down 44.99% over the last year vs S&P 500 Total Return up 18.90%, Prosensa Holding down 67.41%, and PTC Therapeutics up 68.32%.

Get Quote for

PDF Report for SRPT

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download SRPT Pro Report PDF
Advertisement

Portfolio Strategies Featuring SRPT

Did Sarepta Therapeutics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

SRPT Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Company Website: http://www.sareptatherapeutics.com
  • IR Website: http://www.sareptatherapeutics.com/investor-relations
  • HQ Country: United States
  • HQ State/Province: Massachusetts
  • Incorporation Country: United States
  • Incorporation State/Province: Oregon
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: March 31, 2014
  • Last Fiscal Year End: December 31, 2013
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector: Manufacturing

Sarepta Therapeutics Inc discovers and develops RNA-based therapeutics for the treatment of rare and infectious diseases. Its product candidates include eteplirsen, AVI-6002, AVI-6003, and AVI-7100.

SRPT Excel Add-In Codes

  • Name: =YCI("SRPT","name")
  • Description: =YCI("SRPT","description")
  • Sector: =YCI("SRPT","sector")
  • Industry: =YCI("SRPT","industry")
  • Est. Current Fiscal Year End: =YCI("SRPT","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Start My Free Trial"}}

Already a {{root.upsell.info.tier_name}} Member? Sign in here.